Download full-text PDF |
Source |
---|
J Ren Care
March 2025
Department of Nephrology, Odense University Hospital, Odense, Denmark.
Background: Patients with chronic kidney disease and their families request early and continuous advance care planning. Based on user involvement, an advance care planning intervention was developed to support patients, family members and healthcare professionals (HCPs) in advance care planning conversations in a nephrology outpatient setting.
Objective: To explore the experiences and perceptions of an advance care planning intervention among patients with chronic kidney disease, family members and healthcare professionals.
Cleft Palate Craniofac J
January 2025
Seattle Children's Hospital, Craniofacial Center, Seattle, WA, USA.
Objective: To investigate whether differences in early cleft care increase risk of velopharyngeal insufficiency (VPI) after maxillary advancement.
Design: Retrospective cohort study.
Setting: Large pediatric tertiary care hospital.
J Adv Nurs
January 2025
College of Nursing, Guangzhou Medical University, Guangzhou, Guangdong, China.
Aims: To translate the Supportive and Palliative Care Indicators Tool (SPICT) into Chinese and conduct preliminarily tests of its performance in hospitalized patients with cancer.
Design: A cross-sectional validation study conducted from January to March 2024.
Methods: SPICT 2022 was translated in both directions, following the Brislin translation model, and the Chinese version culturally debugged through expert consultation and pre-testing.
J Adv Nurs
January 2025
School of Health, Policing and Sciences, University of Staffordshire, Staffordshire, UK.
Aim: To explore the perceptions and experiences of students raising concerns during pre-registration health and/or social care training in England.
Design: Systematic review.
Data Sources: MEDLINE, CINAHL, ERIC, PsycINFO and Education Research Complete were systematically searched for studies published between September 2015 and August 2024.
Pragmat Obs Res
January 2025
Global Medical Affairs, GSK Consumer Healthcare Singapore Pte. Ltd, Singapore.
In recent years, regulatory authorities have signaled a willingness to consider real-world evidence (RWE) data to support applications for new claims and indications for pharmaceuticals. Historically, RWE studies have been the domain of prescription drugs, driven by the fact that clinical data on patients are routinely captured in medical records, claims databases, registries, etc. However, RWE reports of nonprescription drugs and supplements are relatively sparse due to methodological gaps in this area.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!